Jensen-Jarolim E - Search Results

1

Translating clinical trials from human to veterinary oncology and back.

Fürdös I, Fazekas J, Singer J, Jensen-Jarolim E. Fürdös I, et al. J Transl Med. 2015 Aug 15;13:265. doi: 10.1186/s12967-015-0631-9. J Transl Med. 2015. PMID: 26275615 Free PMC article. Review.

2

Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies.

Weichselbaumer M, Willmann M, Reifinger M, Singer J, Bajna E, Sobanov Y, Mechtcherikova D, Selzer E, Thalhammer JG, Kammerer R, Jensen-Jarolim E. Weichselbaumer M, et al. PLoS Curr. 2011 Mar 16;3:RRN1223. doi: 10.1371/currents.RRN1223. PLoS Curr. 2011. PMID: 21436956 Free PMC article.

3

Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?

Jensen-Jarolim E, Singer J. Jensen-Jarolim E, et al. Clin Exp Allergy. 2011 Oct;41(10):1337-40. doi: 10.1111/j.1365-2222.2011.03764.x. Epub 2011 May 5. Clin Exp Allergy. 2011. PMID: 21545551 Free PMC article. No abstract available.

4

Cancer vaccines inducing antibody production: more pros than cons.

Jensen-Jarolim E, Singer J. Jensen-Jarolim E, et al. Expert Rev Vaccines. 2011 Sep;10(9):1281-9. doi: 10.1586/erv.11.105. Expert Rev Vaccines. 2011. PMID: 21919618 Free article. Review.

5

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting.

Singer J, Weichselbaumer M, Stockner T, Mechtcheriakova D, Sobanov Y, Bajna E, Wrba F, Horvat R, Thalhammer JG, Willmann M, Jensen-Jarolim E. Singer J, et al. Mol Immunol. 2012 Apr;50(4):200-9. doi: 10.1016/j.molimm.2012.01.002. Mol Immunol. 2012. PMID: 22424313 Free PMC article.

6

IgE-based immunotherapy of cancer: challenges and chances.

Singer J, Jensen-Jarolim E. Singer J, et al. Allergy. 2014 Feb;69(2):137-49. doi: 10.1111/all.12276. Epub 2013 Oct 14. Allergy. 2014. PMID: 24117861 Free PMC article. Review.

7

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.

Petricevic B, Laengle J, Singer J, Sachet M, Fazekas J, Steger G, Bartsch R, Jensen-Jarolim E, Bergmann M. Petricevic B, et al. J Transl Med. 2013 Dec 12;11:307. doi: 10.1186/1479-5876-11-307. J Transl Med. 2013. PMID: 24330813 Free PMC article.

8

Epicutaneously applied Der p 2 induces a strong TH 2-biased antibody response in C57BL/6 mice, independent of functional TLR4.

Stremnitzer C, Manzano-Szalai K, Starkl P, Willensdorfer A, Schrom S, Singer J, Reichart U, Akira S, Jensen-Jarolim E. Stremnitzer C, et al. Allergy. 2014 Jun;69(6):741-51. doi: 10.1111/all.12399. Epub 2014 Apr 16. Allergy. 2014. PMID: 24735481 Free PMC article.

9

Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.

Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Willmann M, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E. Singer J, et al. Mol Cancer Ther. 2014 Jul;13(7):1777-1790. doi: 10.1158/1535-7163.MCT-13-0288. Epub 2014 Apr 22. Mol Cancer Ther. 2014. PMID: 24755200 Free PMC article.

10

Bet v 1 from birch pollen is a lipocalin-like protein acting as allergen only when devoid of iron by promoting Th2 lymphocytes.

Roth-Walter F, Gomez-Casado C, Pacios LF, Mothes-Luksch N, Roth GA, Singer J, Diaz-Perales A, Jensen-Jarolim E. Roth-Walter F, et al. J Biol Chem. 2014 Jun 20;289(25):17416-21. doi: 10.1074/jbc.M114.567875. Epub 2014 May 5. J Biol Chem. 2014. PMID: 24798325 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters